Ventyx Biosciences Reports Second Quarter 2023 Financial Results and Highlights Recent Corporate Progress

Go back to Ventyx Biosciences Reports Second Quarter 2023 Financial Results and Highlights Recent Corporate Progress

Ventyx Biosciences, Inc. (VTYX) Misses Q2 EPS by 21c

August 10, 2023 4:04 PM EDT

Ventyx Biosciences, Inc. (NASDAQ: VTYX) reported Q2 EPS of ($0.91), $0.21 worse than the analyst estimate of ($0.70).

For earnings history and earnings-related data on Ventyx Biosciences, Inc. (VTYX) click here.

... More